KRT7 and neoplasm: RO often has a CD117+/ minimal CK7+ (clusters less than 5% of tumor) immunophenotype, uniform nuclei with minimal atypia, mitochondrial gene mutations, and recurrent chromosomal losses (1, 14, 21, X, and Y).